|
Delayed
Australian S.E.
05:07:42 16/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 3.575 AUD | +1.27% |
|
+3.62% | +58.19% |
| 10-12 | Cogstate Contracted Fiscal 2027 Revenue Rises to $56.8 Million After September Quarter Sales | MT |
| 09-25 | Morgans Financial Starts Cogstate at Buy with AU$4.07 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COGSTATE LIMITED | Other Biotechnology & Medical Research | +1.27% | +3.62% | +58.19% | +37.50% | +50.21% | 436M |  | | |
- Stock Market
- Stocks
- CGS Stock
- Charts Cogstate Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
